At1g51120 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g51120 antibody; F23H24.5 antibody; AP2/ERF and B3 domain-containing transcription factor At1g51120 antibody; RAV1-like ethylene-responsive transcription factor At1g51120 antibody
Target Names
At1g51120
Uniprot No.

Target Background

Function
At1g51120 Antibody is believed to function as a transcriptional activator. It binds to the GCC-box pathogenesis-related promoter element, suggesting a role in regulating gene expression. This regulation may be influenced by stress factors and components of stress signal transduction pathways.
Database Links

KEGG: ath:AT1G51120

STRING: 3702.AT1G51120.1

UniGene: At.50656

Protein Families
AP2/ERF transcription factor family, RAV subfamily
Subcellular Location
Nucleus.

Q&A

What is At1g51120 and why are antibodies against it important in plant research?

At1g51120 is a gene locus in Arabidopsis thaliana that encodes a specific protein. Antibodies targeting this protein are crucial tools for studying its expression, localization, and function in plant developmental processes. Monoclonal antibodies developed against plant proteins like At1g51120 enable researchers to identify and quantify these proteins, contributing to our understanding of plant cellular structures and developmental mechanisms . These antibodies serve as molecular markers for studying specific cell layers and developmental stages in plant tissues, particularly in floral development research.

How are antibodies against plant proteins like At1g51120 typically generated?

Generating antibodies against plant proteins typically involves using total protein extracts from specific plant tissues as antigens. For At1g51120-specific antibodies, researchers often use protein extracts from Arabidopsis inflorescences. The process involves:

  • Extracting total proteins from target tissues (e.g., Arabidopsis inflorescences)

  • Immunizing host animals with these protein extracts

  • Screening the resulting antibodies using Western blot to identify those that recognize specific protein bands

  • Further characterizing antibody specificity through immunofluorescence microscopy

  • Confirming target antigens using immunoprecipitation followed by mass spectrometry analysis

This approach has been successful in generating monoclonal antibodies that can specifically recognize plant proteins in complex samples, enabling detailed study of protein expression patterns across different tissues and developmental stages.

What are the typical applications of At1g51120 antibody in plant developmental studies?

At1g51120 antibodies have several important applications in plant developmental research:

  • Protein localization studies: Using immunofluorescence microscopy to determine the spatial distribution of At1g51120 protein within specific cell layers of plant tissues

  • Protein expression analysis: Employing Western blotting to analyze protein expression levels across different plant organs (stems, leaves, inflorescences) and developmental stages

  • Protein-protein interaction studies: Utilizing immunoprecipitation to identify protein complexes containing the At1g51120 protein

  • Developmental marker: Serving as a molecular marker for specific cell types or developmental stages in plant tissues

  • Functional studies: Supporting investigations into protein function by correlating protein presence with phenotypic characteristics

These applications make At1g51120 antibody an invaluable tool for researchers studying plant development, particularly floral organ development in Arabidopsis.

How can I validate the specificity of an At1g51120 antibody for my experiments?

Validating antibody specificity is crucial for generating reliable research data. For At1g51120 antibody, consider these validation approaches:

  • Western blot analysis: Test the antibody against protein extracts from different plant tissues. A specific antibody should detect a single band of the expected molecular weight for At1g51120 .

  • Knockout/knockdown controls: Test the antibody in tissues where At1g51120 expression has been genetically eliminated or reduced. The specific signal should be absent or diminished in these samples .

  • Immunoprecipitation followed by mass spectrometry: Perform IP with the antibody and analyze the enriched proteins by MS to confirm that At1g51120 is among the identified proteins .

  • Immunofluorescence with positive and negative controls: Compare staining patterns in tissues known to express versus not express At1g51120.

  • Recombinant protein control: Test the antibody against purified recombinant At1g51120 protein to confirm recognition.

Validation MethodExpected Result for Specific AntibodyCommon Pitfalls
Western blotSingle band at expected MWMultiple bands, unexpected MW
Knockout controlAbsence of signalPersistent signal indicating non-specificity
IP-MSAt1g51120 among top hitsUnrelated proteins dominating results
ImmunofluorescencePattern consistent with known expressionUbiquitous staining, background
Recombinant proteinStrong signal with dose-dependencyWeak or no signal

What controls should I include when using At1g51120 antibody in my experiments?

Proper controls are essential when working with antibodies like At1g51120:

  • Negative controls:

    • Secondary antibody-only control to detect non-specific binding of the secondary antibody

    • Isotype control using an irrelevant antibody of the same isotype to identify non-specific binding

    • Pre-immune serum control (for polyclonal antibodies)

    • Tissue known not to express At1g51120

  • Positive controls:

    • Tissues known to express At1g51120 at high levels

    • Recombinant At1g51120 protein

    • Previously validated samples

  • Procedural controls:

    • Include proper blocking steps to minimize non-specific binding

    • Perform titration experiments to determine optimal antibody concentration

    • Include viability controls to exclude dead cells that bind antibodies non-specifically

  • Cross-reactivity controls:

    • Test the antibody against homologous proteins to assess potential cross-reactivity

    • Use cross-adsorbed secondary antibodies when performing multiplex experiments

These controls help distinguish true positive signals from background and artifacts, ensuring the reliability of your experimental results.

How do antibodies against plant proteins like At1g51120 differ from those targeting mammalian proteins?

Antibodies against plant proteins like At1g51120 present unique considerations compared to mammalian antibodies:

  • Antigen accessibility: Plant cell walls can limit antibody penetration, requiring special fixation and permeabilization protocols for immunolabeling.

  • Background interference: Plant tissues contain various compounds that can cause autofluorescence and non-specific binding, necessitating additional blocking and washing steps .

  • Validation challenges: Fewer commercially validated plant antibodies exist, requiring more rigorous validation by individual researchers.

  • Cross-reactivity concerns: Plant protein families often contain many closely related members, increasing the risk of cross-reactivity.

  • Epitope conservation: When using antibodies across plant species, epitope conservation must be carefully assessed.

  • Optimization requirements: Protocols optimized for mammalian systems often require significant adaptation for plant tissues.

  • Tissue-specific expression: Plant proteins like At1g51120 may show highly tissue-specific expression patterns that vary throughout development, requiring careful experimental design and interpretation .

Understanding these differences is essential for successfully applying antibody-based techniques to plant research.

What is the optimal experimental design for Western blot analysis using At1g51120 antibody?

Optimal Western blot protocols for At1g51120 antibody should include:

  • Sample preparation:

    • Extract proteins from tissues known to express At1g51120 (e.g., Arabidopsis inflorescences)

    • Use appropriate extraction buffers with protease inhibitors to prevent degradation

    • Quantify protein concentration and load equal amounts (typically 10-30 μg)

  • Electrophoresis and transfer:

    • Select appropriate gel percentage based on At1g51120's molecular weight

    • Include molecular weight markers

    • Optimize transfer conditions for the protein's size

  • Antibody incubation:

    • Block membrane thoroughly to reduce background (typically 5% non-fat milk or BSA)

    • Titrate primary At1g51120 antibody to determine optimal concentration

    • Use appropriate dilution of HRP-conjugated secondary antibody

  • Controls and validation:

    • Run independent blots with single primary antibodies before multiplexing

    • Include positive and negative tissue controls

    • Consider using recombinant At1g51120 as a positive control

  • Detection optimization:

    • Choose detection reagents appropriate for expected expression level

    • Optimize exposure time to avoid saturation

    • Consider quantitative analysis using appropriate software

StepParameterRecommended RangeNotes
BlockingDuration1-2 hoursLonger for high background
Primary antibodyDilution1:500-1:2000Titrate for optimal signal-to-noise
Primary antibodyIncubation4°C overnightCan improve specificity
Secondary antibodyDilution1:2000-1:10000Dependent on detection method
WashingNumber3-5 timesCritical for reducing background
WashingDuration5-10 min eachThorough washing improves results

How should I design immunoprecipitation experiments with At1g51120 antibody?

Effective immunoprecipitation (IP) with At1g51120 antibody requires careful experimental design:

  • Sample preparation:

    • Extract proteins under non-denaturing conditions to preserve protein-protein interactions

    • Use buffers that maintain protein stability while enabling antibody binding

    • Clear lysates by centrifugation to remove debris that could cause non-specific binding

  • Pre-clearing step:

    • Incubate lysates with protein A/G beads without antibody to remove proteins that bind non-specifically to beads

  • Antibody binding:

    • Determine optimal antibody amount through titration experiments

    • Incubate lysate with At1g51120 antibody (typically 2-5 μg per mg of total protein)

    • Allow sufficient incubation time (2-4 hours or overnight at 4°C)

  • Precipitation and washing:

    • Use appropriate protein A/G beads based on antibody isotype

    • Optimize wash stringency to remove non-specific binders while retaining specific interactions

    • Perform multiple washes with decreasing salt concentrations

  • Controls and validation:

    • Include an IgG control from the same species as the At1g51120 antibody

    • Validate IP efficiency by Western blot analysis of input, unbound, and IP fractions

    • Confirm specific enrichment using mass spectrometry analysis

Previous successful IPs with plant antibodies have used this approach to identify At1g51120-binding partners, enabling the discovery of protein-protein interactions and protein complexes involved in plant development .

What approaches can I use to optimize immunofluorescence with At1g51120 antibody in plant tissues?

Optimizing immunofluorescence with At1g51120 antibody in plant tissues requires addressing several challenges:

  • Tissue fixation and preparation:

    • Test different fixatives (paraformaldehyde, glutaraldehyde) and concentrations

    • Optimize fixation time to preserve antigen while enabling antibody penetration

    • For paraffin sections, evaluate different antigen retrieval methods

  • Blocking and permeabilization:

    • Use plant-appropriate blocking agents (BSA, normal serum, milk powder)

    • Test different permeabilization approaches (Triton X-100, saponin, methanol)

    • Extend blocking time to reduce plant tissue-specific background

  • Antibody parameters:

    • Titrate primary antibody concentration (typically 1:50-1:500 for plant tissues)

    • Optimize incubation temperature and time (4°C overnight often works best)

    • Select fluorophore-conjugated secondary antibodies with spectra distinct from plant autofluorescence

  • Signal enhancement strategies:

    • Consider tyramide signal amplification for low-abundance proteins

    • Evaluate biotin-streptavidin systems for signal amplification

    • Test different mounting media to preserve fluorescence and reduce photobleaching

  • Microscopy optimization:

    • Use confocal microscopy to reduce background from out-of-focus light

    • Adjust acquisition parameters to distinguish signal from plant autofluorescence

    • Consider spectral unmixing for challenging samples

Successfully optimized immunofluorescence protocols have revealed specific localization patterns of plant proteins in Arabidopsis inflorescence sections, highlighting expression in specific cell layers .

How can I use At1g51120 antibody to study protein-protein interactions in plant developmental pathways?

At1g51120 antibody can be powerfully applied to study protein-protein interactions through several advanced approaches:

  • Co-immunoprecipitation followed by mass spectrometry:

    • Use At1g51120 antibody to pull down the protein complex

    • Analyze the precipitated proteins by mass spectrometry to identify interacting partners

    • Quantitative MS approaches can determine the relative abundance of interactors

    • Previous studies have successfully identified interaction partners for plant proteins using this approach

  • Proximity-based labeling:

    • Create fusion proteins of At1g51120 with proximity labeling enzymes (BioID, APEX)

    • Use the At1g51120 antibody to validate expression and localization of the fusion protein

    • Identify proteins in close proximity to At1g51120 in vivo

  • Co-localization studies:

    • Perform dual immunofluorescence with At1g51120 antibody and antibodies against suspected interaction partners

    • Use super-resolution microscopy techniques to assess spatial proximity

    • Quantify co-localization using appropriate statistical methods

  • Förster resonance energy transfer (FRET):

    • Use fluorophore-conjugated At1g51120 antibody in combination with antibodies against potential interaction partners

    • Measure energy transfer between fluorophores as evidence of protein proximity

    • This approach works particularly well for fixed samples in plant tissues

  • Validation of interaction networks:

    • Use At1g51120 antibody to validate interactions identified through other methods (Y2H, BiFC)

    • Assess interactions under different developmental conditions or stress treatments

    • Map interaction dynamics throughout plant development

These approaches can reveal how At1g51120 functions within protein complexes and signaling networks during plant development.

What are the latest techniques for combining At1g51120 antibody with other molecular markers for multi-dimensional analysis?

Advanced multi-dimensional analysis using At1g51120 antibody can provide deeper insights into plant biology:

  • Multiplex immunofluorescence:

    • Combine At1g51120 antibody with other antibodies against markers of interest

    • Use antibodies from different host species or isotype-specific secondary antibodies to avoid cross-reactivity

    • Apply spectral imaging and unmixing to separate signals from multiple fluorophores

    • This approach has been successful in identifying cell-type specific expression patterns in plant tissues

  • Correlative light and electron microscopy (CLEM):

    • Use At1g51120 antibody for fluorescence microscopy to identify regions of interest

    • Process the same sample for electron microscopy to obtain ultrastructural information

    • Overlay images to correlate protein localization with subcellular structures

  • Single-cell analysis integration:

    • Combine immunofluorescence data with single-cell transcriptomics

    • Correlate protein expression (detected by antibody) with mRNA expression

    • Create integrated maps of gene expression at both RNA and protein levels

  • Multi-omics approaches:

    • Use At1g51120 antibody for spatial proteomics

    • Integrate with transcriptomics, metabolomics, and phenomics data

    • Develop comprehensive models of developmental processes

  • Tissue clearing and 3D imaging:

    • Apply tissue clearing techniques compatible with antibody staining

    • Perform whole-mount immunofluorescence with At1g51120 antibody

    • Generate 3D reconstructions of protein expression patterns throughout plant organs

These multi-dimensional approaches provide a more comprehensive understanding of At1g51120's role in plant development by placing its expression in broader molecular and cellular contexts.

How can antibody characterization approaches like those used by YCharOS be applied to plant antibodies including At1g51120?

The systematic antibody characterization approaches pioneered by YCharOS can be adapted for plant antibodies including At1g51120:

  • Standardized validation pipeline:

    • Establish a consistent validation workflow for plant antibodies

    • Include multiple validation methods (Western blot, IP, IF) for each antibody

    • Generate knockout/knockdown lines in model plant species for validation

  • Open science collaboration:

    • Coordinate with antibody manufacturers to characterize plant antibodies

    • Share characterization data through open access platforms

    • Create a community database of validated plant antibodies

  • Use of advanced negative controls:

    • Generate CRISPR knockout lines of At1g51120 in Arabidopsis

    • Use these lines as definitive negative controls for antibody testing

    • Apply this approach systematically across different antibodies

  • Renewable antibody development:

    • Shift from hybridoma-based to recombinant antibody production

    • Ensure consistent supply of well-characterized antibodies

    • Enable antibody engineering to improve specificity and performance

  • Multi-laboratory validation:

    • Test At1g51120 antibody performance across different research groups

    • Establish reproducibility metrics for antibody performance

    • Create benchmarking standards for plant antibodies

Implementing these approaches would address many of the reproducibility challenges in plant antibody research, similar to improvements seen in neuroscience antibodies through the YCharOS initiative .

How do I address contradictory results when using At1g51120 antibody across different experimental techniques?

When faced with contradictory results using At1g51120 antibody across different techniques, consider these systematic troubleshooting approaches:

  • Antibody validation reassessment:

    • Revalidate antibody specificity using multiple methods

    • Confirm antibody recognizes the intended target through IP-MS

    • Check if antibody recognizes different forms of the protein (phosphorylated, glycosylated, etc.)

  • Technique-specific optimization:

    • Different techniques may require different antibody concentrations

    • Optimize sample preparation protocols for each technique separately

    • Consider that epitope accessibility may vary between techniques

  • Biological context analysis:

    • Evaluate if contradictions relate to different biological conditions

    • Consider developmental timing, tissue specificity, and environmental conditions

    • Protein expression levels may vary drastically between tissues

  • Cross-reactivity investigation:

    • Test for cross-reactivity with homologous proteins

    • Perform competition assays with recombinant protein

    • Consider using more specific secondary antibodies

  • Data integration approach:

    • Generate a comprehensive dataset using multiple techniques

    • Identify patterns and exceptions in the data

    • Develop models that can explain apparent contradictions

What factors might affect the sensitivity and reproducibility of At1g51120 antibody detection, and how can they be addressed?

Several factors can impact sensitivity and reproducibility when using At1g51120 antibody:

  • Antibody-related factors:

    • Batch-to-batch variability in antibody production

    • Antibody degradation during storage

    • Potential cross-reactivity with related proteins

  • Sample preparation factors:

    • Variations in protein extraction efficiency

    • Protein degradation during sample processing

    • Post-translational modifications affecting epitope recognition

  • Protocol variables:

    • Inconsistent blocking procedures

    • Variations in incubation times and temperatures

    • Differences in detection systems and their sensitivity

  • Plant-specific challenges:

    • Developmental stage variations in protein expression

    • Environmental conditions affecting protein levels

    • Tissue-specific interfering compounds

FactorPotential SolutionImplementation Approach
Antibody variabilityUse recombinant antibodiesSwitch to defined recombinant antibodies for consistency
Sample degradationOptimize extraction buffersInclude appropriate protease inhibitors and process samples rapidly
Protocol inconsistencyStandardize protocolsDevelop detailed SOPs with specific timing and reagent information
Environmental variationControl growth conditionsUse growth chambers with defined parameters for reproducibility
Interfering compoundsOptimize blocking/washingTest different blocking agents and extended washing protocols

Addressing these factors systematically can significantly improve reproducibility, as demonstrated by studies showing that properly validated antibodies provide consistent results across different experimental conditions .

How can I integrate At1g51120 antibody data with transcriptomic data to understand gene regulation in plants?

Integrating At1g51120 antibody-based protein data with transcriptomics provides powerful insights into plant gene regulation:

  • Correlation analysis:

    • Measure At1g51120 protein levels using quantitative Western blot or immunofluorescence

    • Correlate with mRNA expression from the same tissues using RT-qPCR or RNA-seq

    • Identify potential post-transcriptional regulation when protein and mRNA levels diverge

  • Temporal dynamics comparison:

    • Track At1g51120 protein expression over a developmental time course using the antibody

    • Compare with mRNA expression dynamics from transcriptomic data

    • Identify time lags between transcription and protein accumulation

  • Cell-type specific integration:

    • Use immunofluorescence with At1g51120 antibody to identify cell-type specific expression

    • Compare with cell-type specific transcriptomics (FACS-seq, single-cell RNA-seq)

    • Create integrated maps of transcript and protein distribution

  • Perturbation response analysis:

    • Examine how At1g51120 protein levels (detected by antibody) respond to environmental stimuli

    • Compare with transcriptional responses to the same stimuli

    • Identify discordant responses that suggest post-transcriptional regulation

  • Multi-omics data integration:

    • Combine antibody-based proteomics, transcriptomics, and potentially epigenomics data

    • Use computational methods (e.g., weighted gene co-expression networks) to identify regulatory modules

    • Develop predictive models of gene regulation incorporating both transcriptional and post-transcriptional mechanisms

This integrated approach has revealed important insights into plant development, showing that protein levels do not always directly correlate with transcript levels due to various regulatory mechanisms .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.